IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
71.43
-1.57 (-2.15%)
Aug 13, 2025, 4:00 PM - Market closed
IRADIMED CORPORATION Market Cap
IRADIMED CORPORATION has a market cap or net worth of $903.12 million as of August 14, 2025. Its market cap has increased by 52.63% in one year.
Market Cap
903.12M
Enterprise Value
850.12M
1-Year Change
52.63%
Ranking
Category
Stock Price
$71.43
Market Cap Chart
Since July 16, 2014, IRADIMED CORPORATION's market cap has increased from $100.50M to $903.12M, an increase of 798.63%. That is a compound annual growth rate of 21.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 903.10M | 29.57% |
| Dec 31, 2024 | 697.00M | 16.48% |
| Dec 29, 2023 | 598.40M | 68.33% |
| Dec 30, 2022 | 355.50M | -37.66% |
| Dec 31, 2021 | 570.30M | 103.90% |
| Dec 31, 2020 | 279.70M | 4.17% |
| Dec 31, 2019 | 268.50M | 0.37% |
| Dec 31, 2018 | 267.50M | 67.29% |
| Dec 29, 2017 | 159.90M | 34.48% |
| Dec 30, 2016 | 118.90M | -61.68% |
| Dec 31, 2015 | 310.30M | 122.44% |
| Dec 31, 2014 | 139.50M | 38.81% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.31B |
| Johnson & Johnson | 418.67B |
| AbbVie | 354.76B |
| UnitedHealth Group | 244.62B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.27B |
| Novo Nordisk | 223.00B |